ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 227 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,147 | -13.0% | 199 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $4,766 | +27.3% | 199 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,745 | +18.2% | 199 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $3,168 | -36.6% | 199 | -29.2% | 0.00% | -33.3% |
| Q3 2022 | $5,000 | +25.0% | 281 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $4,000 | -42.9% | 281 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $7,000 | +40.0% | 281 | 0.0% | 0.00% | +33.3% |
| Q3 2021 | $5,000 | -28.6% | 281 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $7,000 | 0.0% | 281 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | -53.3% | 281 | 0.0% | 0.00% | -60.0% |
| Q4 2020 | $15,000 | +15.4% | 281 | 0.0% | 0.01% | -23.1% |
| Q2 2020 | $13,000 | -27.8% | 281 | -42.9% | 0.01% | +8.3% |
| Q3 2019 | $18,000 | +28.6% | 492 | -5.7% | 0.01% | +33.3% |
| Q2 2019 | $14,000 | 0.0% | 522 | 0.0% | 0.01% | -18.2% |
| Q1 2019 | $14,000 | +27.3% | 522 | -5.1% | 0.01% | +120.0% |
| Q3 2018 | $11,000 | – | 550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |